Home » Alnara Bags $35 Million B Round, to Seek Approval for Cystic Fibrosis Drug
Alnara Bags $35 Million B Round, to Seek Approval for Cystic Fibrosis Drug
Alnara Pharmaceuticals … says it has nabbed $35 million
in a Series B funding round as it puts the finishing touches on the paperwork it needs to complete before asking the FDA for permission to sell its first
product, an enzyme-replacement drug for patients with cystic fibrosis.
Xconomy
Xconomy
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May